BiotechTube

Apitegromab + Nusinersen + Risdiplam

Phase 2Recruiting
0 watching 0 views this week⚡ Active
49
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Spinal Muscular Atrophy

Conditions

Spinal Muscular Atrophy, SMA, Spinal Muscular Atrophy Type 2, Spinal Muscular Atrophy Type 3, Neuromuscular Manifestations, Anti-myostatin

Trial Timeline

Sep 15, 2025 → Mar 1, 2029

NCT ID
NCT07047144

About Apitegromab + Nusinersen + Risdiplam

Apitegromab + Nusinersen + Risdiplam is a phase 2 stage product being developed by Scholar Rock Holding for Spinal Muscular Atrophy. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07047144. Target conditions include Spinal Muscular Atrophy, SMA, Spinal Muscular Atrophy Type 2.

Hype Score Breakdown

Clinical
17
Activity
12
Company
7
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT07047144Phase 2Recruiting

Competing Products

20 competing products in Spinal Muscular Atrophy

See all competitors
ProductCompanyStageHype Score
SUN13837 injection + PlaceboDaiichi SankyoPhase 2
52
Placebo + Reldesemtiv 150 mg + Reldesemtiv 450 mgAstellas PharmaPhase 2
52
Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor CellsSun PharmaceuticalPhase 2
52
Allogeneic Human Induced Pluripotent Stem Cell (iPSC)-Derived Motor Neuron Progenitor CellsSun PharmaceuticalPhase 1
33
ElezanumabAbbViePre-clinical
23
Elezanumab + PlaceboAbbViePhase 2
52
Ropivacaine + BupivacaineAstraZenecaPhase 3
77
Onasemnogene Abeparvovec-xioiNovartisPhase 1
33
ZolgensmaNovartisPre-clinical
23
BVS857 + PlaceboNovartisPhase 2
52
AVXS-101NovartisPhase 1
33
Onasemnogene Abeparvovec-xioiNovartisPhase 3
77
Onasemnogene Abeparvovec-brveNovartisApproved
85
Onasemnogene Abeparvovec-xioiNovartisPre-clinical
23
Onasemnogene Abeparvovec-xioiNovartisPhase 3
77
branaplamNovartisPhase 1/2
41
Onasemnogene Abeparvovec-xioiNovartisPhase 3
77
onasemnogene abeparvovecNovartisPhase 3
77
onasemnogene abeparvovec-xioiNovartisPhase 3
77
RisdiplamRochePhase 1
33

Other Products from Scholar Rock Holding

Apitegromab + PlaceboPhase 3
74
ApitegromabPhase 3
74
Apitegromab + PlaceboPhase 2
49
SRK-015Phase 2
49
Apitegromab + Placebo + TirzepatidePhase 2
49